TotalMarketCap

C4 Therapeutics

CCCCNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$362.309 M

$2.95 -5.61%

Close of 6 Nov 2026

As of 6 Nov 2026, C4 Therapeutics (CCCC) has a market capitalization of $362.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$35.9M

#2815 by revenue

Earnings

-$105.0M

Loss-making

Shares outstanding

131,317,488

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #70Allogene TherapeuticsALLO$380.0M
  2. #71TevogenTVGN$377.4M
  3. #72C4 TherapeuticsCCCC$362.3M
  4. #73Zura BioZURA$362.2M
  5. #74TRex BioTRXB$355.7M

What if C4 Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$229,521.18

Per share 77,936× higher

Bitcoin $1.53T

$12,418.99

Per share 4,217× higher

Apple $5.02T

$40,770.39

Per share 13,844× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for C4 Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.